Simplex Trading
TXG icon

Simplex Trading’s 10x Genomics TXG Stock Holding History

Simplex Trading’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,986
Closed -$320K – 10210
2025
Q4 		$261K Buy
+15,986
New +$241K ﹤0.01% 3960
2025
Q1 		– Sell
-5,224
Closed -$65.9K – 9727
2024
Q4 		$75K Buy
5,224
+2,055
+65% +$32.4K ﹤0.01% 5458
2024
Q3 		$71K Buy
+3,169
New +$65.5K ﹤0.01% 5557
2024
Q1 		– Sell
-14,200
Closed -$624K – 9931
2023
Q4 		$794K Buy
14,200
+1,468
+12% +$63.9K ﹤0.01% 3244
2023
Q3 		$525K Buy
12,732
+7,637
+150% +$397K ﹤0.01% 3349
2023
Q2 		$284K Buy
+5,095
New +$276K ﹤0.01% 3914
2023
Q1 		– Sell
-1,053
Closed -$49.2K – 10174
2022
Q4 		$38K Sell
1,053
-15,852
-94% -$518K ﹤0.01% 6206
2022
Q3 		$481K Buy
16,905
+12,702
+302% +$484K ﹤0.01% 3517
2022
Q2 		$190K Buy
+4,203
New +$218K ﹤0.01% 4679
2021
Q2 		– Sell
-471
Closed -$85.2K – 10732
2021
Q1 		$85K Buy
+471
New +$81.3K ﹤0.01% 5962
2020
Q2 		– Sell
-157
Closed -$12.2K – 8386
2020
Q1 		$9K Sell
157
-209
-57% -$16.3K ﹤0.01% 6553
2019
Q4 		$27K Buy
+366
New +$22K ﹤0.01% 5741

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's TXG Position: Q1 2026 in Review

Simplex Trading sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 15,986 shares — an estimated $320K sold.

Simplex Trading first reported a position in TXG in Q4 2019 and held it in 12 quarters. The position peaked at $794K in Q4 2023. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Simplex Trading reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 15,986 10x Genomics shares in Q1 2026, an estimated $320K.
  • Simplex Trading first reported a position in 10x Genomics in Q4 2019 and held it in 12 quarters.
  • Simplex Trading's 10x Genomics position peaked at $794K in Q4 2023.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.